Yamada J, Sugimoto Y, Noma T, Yoshikawa T (October 1998). «Effects of the non-selective 5-HT receptor agonist, 5-carboxamidotryptamine, on plasma glucose levels in rats». European Journal of Pharmacology359 (1): 81-86. PMID9831297. doi:10.1016/S0014-2999(98)00617-7.
Wright CE, Angus JA (April 1989). «5-carboxamidotryptamine elicits 5-HT2 and 5-HT3 receptor-mediated cardiovascular responses in the conscious rabbit: evidence for 5-HT release from platelets». Journal of Cardiovascular Pharmacology13 (4): 557-564. PMID2470992. doi:10.1097/00005344-198913040-00007.
Yamada J, Sugimoto Y, Noma T, Yoshikawa T (October 1998). «Effects of the non-selective 5-HT receptor agonist, 5-carboxamidotryptamine, on plasma glucose levels in rats». European Journal of Pharmacology359 (1): 81-86. PMID9831297. doi:10.1016/S0014-2999(98)00617-7.
Wright CE, Angus JA (April 1989). «5-carboxamidotryptamine elicits 5-HT2 and 5-HT3 receptor-mediated cardiovascular responses in the conscious rabbit: evidence for 5-HT release from platelets». Journal of Cardiovascular Pharmacology13 (4): 557-564. PMID2470992. doi:10.1097/00005344-198913040-00007.
Saxena PR, Lawang A (October 1985). «A comparison of cardiovascular and smooth muscle effects of 5-hydroxytryptamine and 5-carboxamidotryptamine, a selective agonist of 5-HT1 receptors». Archives Internationales de Pharmacodynamie et de Therapie277 (2): 235-252. PMID2933009.